Xpedite® Ventures Ltd
In order to bridge the gap between proof-of-concept and later stage venture finance, Xpedite® Ventures Limited (XVL) is currently raising a £12 million fund for which the UK Government (Department of Business, Innovation and Skills) has provided a £2 million acorn commitment.
XVL has set out to be a specialist healthcare sector seed investor; our sole purpose being to invest in sound fledgling business propositions with novel healthcare products, technologies and services.
XVL aims to bring promising ideas with marketable prospects to profitable conclusions - from proof of concept to proof of commerce and beyond.
Get in touch, you'll see we offer a great deal more than just finance.
Xpedite® Ventures Limited is authorised and regulated in the UK by the Financial Services Authority ("FSA"). Further details are available from the FSA Register at www.fsa.gov.uk/register. Xpedite® Ventures Limited is registered in England and Wales No 6027071 the registered office is NHS Innovations London Ltd, 4th Floor, Audrey House, 16-20 Ely Place, London EC1N 6SN.
Note: Xpedite® Ventures Ltd is not associated with Expedite Ventures or any business of a similar name operating in the United States. The contents of this website have been issued for the purposes of section 21 of the Financial Services and Markets Act 2000 by Xpedite® Ventures Limited.
Please check out the Important Notice.
